Posts by: Jose Marques Lopes, PhD

News

Virgin olive oil, especially its phenol components, showed anti-inflammatory properties in mice with systemic lupus erythematosus (SLE) and in human immune cells, according to a new Spanish study. The findings ... Read more

August 6, 2018

Lupus Patients Show Signs of Heart Problems at Diagnosis, Study Finds

News

At the time of diagnosis, systemic lupus erythematosus (SLE) patients already show signs of heart impairment, even before any symptoms of chest discomfort, a new imaging study shows. The findings indicate ... Read more

August 3, 2018August 3, 2018

UV Light Sensitivity in Lupus Patients Linked to Interferon Produced by Skin Cells

News

Interferon-kappa (IFN-κ), an immune response regulator, is a key mediator of skin lesions and UV light sensitivity in cutaneous lupus erythematosus patients, a study reports. Its researchers suggest that ... Read more

July 9, 2018July 9, 2018

Lupus Research Alliance Funds Projects Exploring Potential Therapies

News

The Lupus Research Alliance awarded Novel Research Grants to two University of Alabama at Birmingham (UAB) researchers who will use the funds to explore potential targeted treatments for lupus. ... Read more

June 13, 2018June 14, 2018

DxTerity’s LIFT Study Supports Accuracy of Self-Reported Data in Lupus Patients

News

DxTerity Diagnostics’ LIFT study supports the use of social media to rapidly enroll lupus patients for clinical trials, as well as ensuring the accuracy of self-reported data and home-based ... Read more

June 8, 2018

Pediatric Lupus Needs Early Treatment to Reduce Disease Activity, Prevent Organ Damage, Study Says

News

Early treatment to reduce disease activity and prevent irreversible organ damage in pediatric systemic lupus erythematosus (pSLE) patients should be strongly considered, according to new study. The research, “Pediatric ... Read more

May 23, 2018May 23, 2018

Cells that Fight Viruses May Trigger Immune Responses that Make Lupus Worse, Mouse Study Suggests

News

A type of immune cell that protects against viruses and cancer may worsen systemic lupus erythematosus (SLE) and trigger disease flares, a recent study with mice suggests. Led by ... Read more

May 9, 2018May 9, 2018

Lupus a Major Unrecognized Cause of Death in Young Women, Study Reports

News

Systemic lupus erythematosus (SLE) is a major cause of death in young women that goes largely unrecognized due to its exclusion from an annual nationwide ranking, a new U.S. study ... Read more

May 2, 2018May 2, 2018

Teens, Young Women with SLE Have Higher Risk of Adverse Pregnancy Outcomes, Study Shows

News

Teen and young women with systemic lupus erythematosus (SLE) have a higher risk of adverse pregnancy-related outcomes, including hypertensive disorders, maternal death, preterm birth, spontaneous abortion, and induced abortion, according ... Read more

April 4, 2018April 4, 2018

ImmuPharma Expects Top-Line Results of Lupuzor Phase 3 Trial by Mid-April

News

Top-line results of ImmuPharma’s Phase 3 clinical trial testing Lupuzor (rigerimod) as a systemic lupus erythematosus (SLE) treatment are expected by mid-April, according to the company. ImmuPharma also announced that database ... Read more

This is a short description about myself and what this site is about. I hope you enjoy being here!

Posts by: Jose Marques Lopes, PhD

Jose Marques Lopes, PhD

Virgin Olive Oil May Help Reduce SLE Activity, Mouse Study Suggests

Lupus Patients Show Signs of Heart Problems at Diagnosis, Study Finds

UV Light Sensitivity in Lupus Patients Linked to Interferon Produced by Skin Cells

Lupus Research Alliance Funds Projects Exploring Potential Therapies

DxTerity’s LIFT Study Supports Accuracy of Self-Reported Data in Lupus Patients

Pediatric Lupus Needs Early Treatment to Reduce Disease Activity, Prevent Organ Damage, Study Says

Cells that Fight Viruses May Trigger Immune Responses that Make Lupus Worse, Mouse Study Suggests

Lupus a Major Unrecognized Cause of Death in Young Women, Study Reports

Teens, Young Women with SLE Have Higher Risk of Adverse Pregnancy Outcomes, Study Shows

ImmuPharma Expects Top-Line Results of Lupuzor Phase 3 Trial by Mid-April

Pin It on Pinterest